| A randomized trial of factor VIII and neutralizing antibodies in hemophilia A F Peyvandi, PM Mannucci, I Garagiola, A El-Beshlawy, M Elalfy, ... New England Journal of Medicine 374 (21), 2054-2064, 2016 | 514 | 2016 |
| Timing and severity of inhibitor development in recombinant versus plasma‐derived factor VIII concentrates: a SIPPET analysis F Peyvandi, A Cannavò, I Garagiola, R Palla, PM Mannucci, ... Journal of Thrombosis and Haemostasis 16 (1), 39-43, 2018 | 49 | 2018 |
| Source of factor VIII replacement (plasmatic or recombinant) and incidence of inhibitory alloantibodies in previously untreated patients with severe hemophilia A: the … F Peyvandi, PM Mannucci, I Garagiola, M Elalfy, A El-Beshlawy, ... Blood 126 (23), 5, 2015 | 36 | 2015 |
| Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement S Spena, I Garagiola, A Cannavò, M Mortarino, PM Mannucci, ... Journal of Thrombosis and Haemostasis 16 (4), 778-790, 2018 | 32 | 2018 |
| Use of acupuncture in the management of chronic haemophilia pain A Lambing, B Kohn‐Converse, S Hanagavadi, V Varma Haemophilia 18 (4), 613-617, 2012 | 32 | 2012 |
| A clinico-pathological study of hemophilia in rural set up of Karnataka. P Raja, AK Kaler, M Sangeeta, H Suresh, P Sashikala, S Shameem British Journal of Medicine and Medical Research 6 (10), 948-955, 2015 | 12 | 2015 |
| Comparative analysis of oral health and treatment necessities in hemophilia individuals of Davangere population—A case control study V Kanjani, RG Annigeri, S Hanagavadi, MR Manjunath Journal of Family Medicine and Primary Care 9 (9), 4774-4777, 2020 | 6 | 2020 |
| Dental considerations in a patient with haemophilia C Khyati, MG Triveni, R Gopal, AB Tarunkumar, S Hanagavadi, DS Mehta The Journal of Haemophilia Practice 3 (1), 51-54, 2016 | 4 | 2016 |
| Cost-effectiveness analysis of low-dose prophylaxis versus on-demand treatment for moderate-to-severe hemophilia A in India T Seth, K Garg, PK Mandal, A Datta, S Verma, S Hanagavadi, UR Thota Hematology 28 (1), 2277497, 2023 | 2 | 2023 |
| Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia—A in the Sippet Cohort Study F Peyvandi, P Bucciarelli, C Valsecchi, M Boscarino, R Palla, ... Blood 132, 384, 2018 | 1 | 2018 |
| Megakaryocyte changes in thrombocytopenia in bone marrow aspiration SH Ashwini Ratnaker MedPulse International Journal of Pathology. 6 (3), 74-78, 2018 | 1* | 2018 |
| Mutational Repertoire in the SIPPET Cohort and Prediction of FVIII Inhibitor Risk S Spena, I Garagiola, A Cannavò, M Mortarino, A El-Beshlawy, M Elalfy, ... RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS 1 (supp. 1), 169-170, 2017 | 1 | 2017 |
| “Antihemophilic factor is not the only answer for all factor VIII deficiencies.” Case report of odontogenic infection in a patient with hemophilia A, complicated by factor VIII … KM Sudheesh, KSNS Bharani, HY Kiran, S Hanagavadi Indian Journal of Dentistry 7 (3), 149, 2016 | 1 | 2016 |
| Impact of twinning between HTC’s: incremental gain with longitudinal experience J Kuriakose, S Hanagavadi, M Balar, V Pillai, P Kuriakose Haemophilia 22, 54, 2016 | 1 | 2016 |
| Mutational analysis of the F8 gene and phenotypic characterization of Hemophilia A. S Hanagavadi, P Indoria, KS Rajashekar, R Hegde, S Hegde, S Kulkarni, ... Blood Research, 2023 | | 2023 |
| IGG2 AS HALLMARK OF INHIBITOR PERSISTENCE IN PUPS: A LONGITUDINAL ANALYSIS ALONG EXPOSURE TO FVIII S Miri, C Valsecchi, L Schiavone, M Boscarino, R Palla, A El-Beshlawy, ... HAEMATOLOGICA 106 (9), 12-13, 2021 | | 2021 |
| Clinico-Haematological Study of Rare Bleeding Disorders- A 5 year Retrospective Study DTMTR Dr. Nischita Budihal1, Dr. Suresh Hanagavadi , Dr. Rajashekar KS Saudi Journal of Pathology and Microbiology 4 (6), 477-482, 2019 | | 2019 |
| The Influence of F8 Mutation and Thrombophilic Genetic Markers on Bleeding Phenotype of Patients Affected with Severe Hemophilia A in the SIPPET Cohort A Cannavò, S Spena, R Palla, I Garagiola, A El-Beshlawy, M Elalfy, ... RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS 1 (suppl. 1), 797-798, 2017 | | 2017 |
| Prevalence of Inhibitors in Hemophilia-A single centre study P Borah, S Hanagavadi, KS Rajasekhar, MTR Thippeswamy, ... HAEMOPHILIA 22, 69-69, 2016 | | 2016 |
| Inhibitor development in relation to treatment duration in severe hemophilia A in previously untreated patients: results from the sippet trial F Peyvandi, PM Mannucci, I Garagiola, MB Anzoletti, A El-Beshlawy, ... JOURNAL OF THROMBOSIS AND HAEMOSTASIS 13, 321-322, 2015 | | 2015 |
